October 2012

17 October 2012
CYTOO announces today new results that demonstrate the ability of the Company’s 2D+ Cell Culture Platform to reproduce in vivo conditions to analyze tumor cell motility, and in particular to study fibrillar ECM-dependent tumor cell-macrophage pairing and migration involved in tumor metastasis. These results have recently been published in the first issue of the journal IntraVital, edited by Landes Bioscience.  
05 October 2012
We ask for a rapid feedback (6 questions) on your potential interest on new assay development kits currently imagined by CYTOO, with application to Oncology Drug Screening. We would like to recognize your help and send a $20 Starbuck card to the first 50 responders. Thank you for your help on this short survey! The survey is closed, thank you for your participation!